Schedule 3: Hazardous Wastes and Hazardous Recyclable Materials

Biomedical waste - the following wastes, other than those generated from building maintenance, office administration or food preparation and consumption, that are generated by human or animal health care establishments, medical, health care or veterinary teaching or research establishments, clinical laboratories or facilities that test or produce vaccines and needle and syringe exchange programs:

1. human tissues, organs or body parts, excluding teeth, hair or nails;
2. human blood or blood products;
3. human bodily fluids that are contaminated with blood;
4. human bodily fluids removed in the course of autopsy, treatment, or surgery for diagnosis;
5. animal tissues, organs, body parts or carcasses, excluding teeth, nails, hair, bristles, feathers, horns and hooves, resulting from the treatment of an animal for contamination or suspected contamination with one or more of the agents set out in paragraph 2.36(a) or (b) of the Transportation of Dangerous Goods Regulations;
6. animal blood or blood products resulting from the treatment of an animal for contamination or suspected contamination with one or more of the agents set out in paragraph 2.36(a) or (b) of the Transportation of Dangerous Goods Regulations;
7. animal bodily fluids that are visibly contaminated with animal blood and that result from the treatment of an animal for contamination or suspected contamination with one or more of the agents set out in paragraph 2.36(a) or (b) of the Transportation of Dangerous Goods Regulation;
8. animal bodily fluids removed in the course of surgery, treatment or necropsy, and that result from the treatment of an animal for contamination or suspected contamination with one or more of the agents set out in paragraphs 2.36(a) or (b) of the Transportation of Dangerous Goods Regulations;
9. live or attenuated vaccines, human or animal cell cultures, microbiology laboratory cultures, stocks or specimens of microorganisms and any items that have come into contact with them;
10. any items that are saturated with the blood or bodily fluids referred to in paragraphs (b) to (d) or (f) to (h), including items that were saturated but that have dried; and
11. cytotoxic drugs and any items, including tissues, tubing, needles or gloves, that have come into contact with a cytotoxic drug.

Biomedical waste does not include

1. urine or feces;
2. wastes that are controlled under the Health of Animals Act; or
3. wastes that result from the breeding or raising of animals.

Wastes that contain, in a concentration of more than 100 ng/kg of 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent,

1. total polychlorinated dibenzofurans that have a molecular formula C₁₂H_8-nCl_nO in which "n" is greater than 1; or
2. total polychlorinated dibenzo-p-dioxins that have a molecular formula C₁₂H_8-nCl_nO₂ in which "n" is greater than 1.

The concentration is calculated in accordance with "International Toxicity Equivalency Factor (I-TEF) Method of Risk Assessment for Complex Mixtures of Dioxins and Related Compounds", Pilot Study on International Information Exchange on Dioxins and Related Compounds, Committee on the Challenges of Modern Society, North Atlantic Treaty Organization, Report Number 176, August 1988, as amended from time to time, using the following factors: